COVID-19
FDA invokes emergency powers to authorise 30-minute, handheld COVID-19 test
March 27, 2020Medical Communications, Sales and Marketing COVID-19, FDA, Mesa Biotech, US, coronavirus
The FDA invoked Emergency Use Authorization powers to approve a rapid, handheld testing kit for COVID-19 coronavirus cases just days …
Top Ten most popular articles on Pharmafile.com this week
March 27, 2020Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing COVID-19, coronavirus
The COVID-19 global pandemic continues to dominate the news cycle. The first clinical trial using danoprevir (Ganovo) in treating COVID-19 …
British Prime Minister Boris Johnson tests positive for coronavirus
March 27, 2020Medical Communications COVID-19, Coroanvirus
British Prime Minister Boris Johnson has tested positive for coronavirus, developing mild symptoms over the last 24 hours which included …
COVID-19 may significantly hurt the drug supply chains of the biggest pharmaceutical companies
March 27, 2020Medical Communications COVID-19, Coroanvirus, Wuhan Coronavirus, china coronavirus
The increasing spread of the COVID-19 coronavirus pandemic threatens the drug supply lines of the biggest pharmaceutical companies, including AstraZeneca, …
AbbVie won’t defend its patent for Kaletra so it can be made available for coronavirus treatment
March 26, 2020Business Services COVID-19, Ebola Drug, Wuhan Coronavirus, china coronavirus, coronavirus
AbbVie has announce it will not defend its patent to its HIV therapy Kaletra (lopinavir) so it can be made …
FDA approves BMS’ Zeposia in relapsing multiple sclerosis, but COVID-19 will delay its market entry
March 26, 2020Sales and Marketing Bristol-Myers Squibb, COVID-19, Zeposia, coronavirus, multiple sclerosis, pharma
Bristol-Myers Squibb has secured approval with the FDA for Zeposia (ozanimod) 0.92mg in relapsing forms of multiple sclerosis (RMS), but …
FDA will allow doctors to use convalescent plasma to treat critical COVID-19 patients
March 26, 2020Business Services COVID-19, China, Chinese Coronavirus, Wuhan Coronavirus, coronavirus
The FDA have announced they will allow doctors to use convalescent plasma, collected from people who recovered from COVID-19, to …
British government protecting high demand medicine for use in COVID-19 patients
March 25, 2020Research and Development COVID-19, china coronavirus, coronavirus
The British government has implemented new restrictions to protect high demand medicines for coronavirus patients. 80 medicines and being banned …
Results released from first clinical trial using Danoprevir to treat COVID-19
March 25, 2020Research and Development COVID, COVID-19, Wuhan, china coronavirus, coronavirus
The first clinical trial using danoprevir (Ganovo) in treating COVID-19 has released its results, showing that it is safe and …
Eyeforpharma Barcelona 2020 is now a free virtual event
March 25, 2020Medical Communications, Research and Development COVID-19, Eyeforpharma Barcelona 2020, coronavirus, events, eyeforpharma, pharma
In light of the rapidly evolving impact of the COVID-19 virus, eyeforpharma has decided to turn eyeforpharma Barcelona 2020 into …
Demand for hydroxychloroquine soars after Trump says it can treat coronavirus
March 25, 2020Research and Development, Sales and Marketing COVID-19, Wuhan Coronavirus, china coronavirus, coronavirus, covid19
President Trump has continually touted the effectiveness of anti-malaria drug Hydroxychloroquine in treating coronavirus which has led to a jump …
UK begins lockdown as government announce tough measures to stop the spread of COVID-19
March 24, 2020Manufacturing and Production COVID-19, Chinese Coronavirus, Wuhan Coronavirus, coronavirus, coronavirus pandemic, global pandemic
Last night, British Prime Minister Boris Johnson announced sweeping measures to bring Britain into a near total societal lockdown in …
More young coronavirus patients being hospitalised in Europe and US compared to China
March 23, 2020Sales and Marketing COVID-19, Wuhan Coronavirus, china coronavirus, coronavirus
Dr Anthony Fauci, the Director of the National Institute of Allergy and Infectious Disease in the US, said that people …
EMA calls on EU to pool resources together to carry out large scale clinical trials against COVID-19
March 19, 2020Business Services COVID-19, Chinese Coronavirus, Wuhan Coronavirus, coronavirus
The European Medicines Agency (EMA) has called on the European Union to collaborate closely on carrying out clinical trials on …
COVID-19 can survive in aerosol form and on hard surfaces from hours to days, new study shows
March 19, 2020Business Services COVID-19, Wuhan Coronavirus, china coronavirus, coronavirus
New research shows that the COVID-19 coronavirus is stable for hours to days in aerosols and on surfaces. This study was …
Latest content
Long-acting therapies set to reshape HIV treatment market
MHRA approves Romvimza for tenosynovial giant cell tumour
